Effect of High Influenza Activity on Risk of Ventricular Arrhythmias Requiring Therapy in Patients With Implantable Cardiac Defibrillators and Cardiac Resynchronization Therapy Defibrillators

American Journal of Cardiology

Volumn 124, Issue 1, 2019, Pages 44-50

  Madjid, Mohammad ^a   Connolly, Allison T ^b   Nabutovsky, Yelena ^b   Safavi Naeini, Payam ^c   Razavi, Mehdi ^c   Miller, Charles C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ABBOTT LABORATORIES   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DEFIBRILLATION; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ODDS RATIO; PRIORITY JOURNAL; REMOTE SENSING; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; SEX DIFFERENCE; TEMPORAL ANALYSIS; VERY ELDERLY; ADOLESCENT; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; COMPLICATION; HEART ARRHYTHMIA; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INFLUENZA; MIDDLE AGED; PATIENT SELECTION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; INCIDENCE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PATIENT SELECTION; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85064937064     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2019.04.011     Document Type: Article

References (17)

1. Madjid, M., Miller, C.C., Zarubaev, V.V., Marinich, I.G., Kiselev, O.I., Lobzin, Y.V., Filippov, A.E., Casscells, S.W. 3rd, Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 28 (2007), 1205–1210.
2. Warren-Gash, C., Smeeth, L., Hayward, A.C., Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 9 (2009), 601–610.
3. Kwong, J.C., Schwartz, K.L., Campitelli, M.A., Chung, H., Crowcroft, N.S., Karnauchow, T., Katz, K., Ko, D.T., McGeer, A.J., McNally, D., Richardson, D.C., Rosella, L.C., Simor, A., Smieja, M., Zahariadis, G., Gubbay, J.B., Acute myocardial infarction after laboratory-confirmed influenza infection. N Engl J Med 378 (2018), 345–353.
4. Haidari, M., Wyde, P.R., Litovsky, S., Vela, D., Ali, M., Casscells, S.W., Madjid, M., Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice. Atherosclerosis 208 (2010), 90–96.
5. Ciszewski, A., Bilinska, Z.T., Brydak, L.B., Kepka, C., Kruk, M., Romanowska, M., Ksiezycka, E., Przyluski, J., Piotrowski, W., Maczynska, R., Ruzyllo, W., Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 29 (2008), 1350–1358.
6. Naghavi, M., Barlas, Z., Siadaty, S., Naguib, S., Madjid, M., Casscells, W., Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 102 (2000), 3039–3045.
7. Udell, J.A., Zawi, R., Bhatt, D.L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E.B., Farkouh, M.E., Cannon, C.P., Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310 (2013), 1711–1720.
8. Zdarek, J., Israel, C.W., Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical. Herzschrittmacherther Elektrophysiol 27 (2016), 226–239.
9. Zeitler, E.P., Piccini, J.P., Remote monitoring of cardiac implantable electronic devices (CIED). Trends Cardiovasc Med 26 (2016), 568–577.
10. Rolfes, M.A., Foppa, I.M., Garg, S., Flannery, B., Brammer, L., Singleton, J.A., Burns, E., Jernigan, D., Reed, C., Olsen, S.J., Bresee, J., Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States: Centers for Disease Control and Prevention, 2016.
11. Poole, J.E., Johnson, G.W., Hellkamp, A.S., Anderson, J., Callans, D.J., Raitt, M.H., Reddy, R.K., Marchlinski, F.E., Yee, R., Guarnieri, T., Talajic, M., Wilber, D.J., Fishbein, D.P., Packer, D.L., Mark, D.B., Lee, K.L., Bardy, G.H., Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 359 (2008), 1009–1017.
12. Strickberger, S.A., Canby, R., Cooper, J., Coppess, M., Doshi, R., John, R., Connolly, A.T., Roberts, G., Karst, E., Daoud, E.G., Association of antitachycardia pacing or shocks with survival in 69,000 patients with an implantable defibrillator. J Cardiovasc Electrophysiol 28 (2017), 416–422.
13. Ang, L.W., Yap, J., Lee, V., Chng, W.Q., Jaufeerally, F.R., Lam, C.S.P., Cutter, J., Yeo, K.K., Ma, S., Influenza-associated hospitalizations for cardiovascular diseases in the tropics. Am J Epidemiol 186 (2017), 202–209.
14. Moss, A.J., Schuger, C., Beck, C.A., Brown, M.W., Cannom, D.S., Daubert, J.P., Estes, N.A. 3rd, Greenberg, H., Hall, W.J., Huang, D.T., Kautzner, J., Klein, H., McNitt, S., Olshansky, B., Shoda, M., Wilber, D., Zareba, W., MADIT-RIT Trial Investigators. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 367 (2012), 2275–2283.
15. Madjid, M., Aboshady, I., Awan, I., Litovsky, S., Casscells, S.W., Influenza and cardiovascular disease: is there a causal relationship?. Tex Heart Inst J 31 (2004), 4–13.
16. Madjid, M., Alfred, A., Sahai, A., Conyers, J.L., Casscells, S.W., Factors contributing to suboptimal vaccination against influenza: results of a nationwide telephone survey of persons with cardiovascular disease. Tex Heart Inst J 36 (2009), 546–552.
17. Singh, S.M., de Souza, R.J., Kumareswaran, R., Increased defibrillator therapies during influenza season in patients without influenza vaccines. J Arrhythm 31 (2015), 210–214.